Ipilimumab vs Meperidine
Ipilimumab vs Meperidine: Overview
This comparison examines the pharmacological differences between Ipilimumab and Meperidine.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Ipilimumab — Antibody; Meperidine — Small molecule.